Immuno-Oncology 360

Every day millions of people feel the impact of our intelligent devices, advanced analytics and artificial intelligence.

Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way.

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tiss

Parexel is focused on the development of innovative new therapies to improve the world’s health.

Syneos Health® is the only fully integrated end-to-end clinical and commercial solution organization.

Accelerating biological understanding and discovery is more than a mission for 10x Genomics.

Personalis?is a leader in advanced cancer genomics for enabling the next generation of precision cancer therapies and diagnostics.

Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.

Natera is a global leader in providing DNA testing across multiple clinical areas including women's health, organ health, and oncology.

Halloran Consulting Group is a life science consulting firm that provides strategic regulatory, quality, clinical, and organizational support to industry leaders and startup visionaries in the pharmaceutical, biotechnology, and medical device sectors.

Translational Drug Development (TD2) is an oncology-focused Contract Research Organization (CRO) that supports improved and accelerated development of medicines for life-threatening diseases.

Founded in 1997, Scimega is a specialized CRO skilled in collaborative vendor teaming with 23 years unparalleled Canadian oncology experience, 100+ successful oncology clinical trials - never rescued by another CRO.

Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes

Clario generates the richest clinical evidence by fusing our deep scientific expertise and global scale into the broadest endpoint technology platform. By doing this, we empower our partners to transform lives.

Imaging Endpoints (IE) is an imaging research and core laboratory that provides imaging CRO services to evaluate drug and device efficacy.

Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.

In partnership with our Cello Health page on LinkedIn, which demonstrates our Fresh Thinking, this Cello Health Talent page showcases all things People at a global level.

Nilogen Oncosystems is dedicated to streamlining and improving drug development in cancer and immuno-oncology.

Metavi Labs is the technology leader in cellular migration analyses as an essential function in immunological and oncological diagnosis and therapy. We develop high-throughput systems for diagnostic testing and new drug screening.

Helping teams pressure-test/question an organization’s axioms to eliminate, minimize competitive blind spot.

Invicro was founded with a mission of improving the role and function of imaging in translational drug discovery and development.